National

Covid-19

ICMR-Serum Institute recruit first volunteers on Novavax trial

Our Bureau Mumbai | Updated on March 26, 2021

The first three volunteers have been recruited for the Novavax Covid-19 vaccine bridging study, the Indian Council of Medical Research (ICMR) has said.

Also read: India inoculates over 5 crore people against Covid-19

The ICMR has partnered with Serum Institute of India (SII) to conduct Phase II and III bridging trials for Covovax, the vaccine from the US company Novavax. Pune’s Nobel Hospital is one of the trial sites and the volunteers have been given their first short. The trial will enrol 1,600 people.

The development comes evens as some multinationals seek a waiver on such trials during a pandemic, for their vaccines.

Also read: Vaccine shortage: Serum Institute caught in cross-country crossfire

This is the second Covid-19 vaccine that SII brings into India, the first being AstraZeneca-Oxford University’s Covid-19 vaccine that is presently being rolled out in the country and many other countries.

Published on March 26, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.